Challenges in health care delivery have compounded, with clinical staff being exposed to the Omicron COVID variant. Reduced staffing has brought on its challenges to most already-strained state health care systems and the people working in them.
However, over the past 2 years of the pandemic, technology has played an increasing role on the front end for patients and consumers at home and clinicians in the medical setting. Much more is planned in technology that will deliver efficiency, reduce risk and make available new models of care. This has the potential to touch the working lives of all stakeholders and recipients of care.
Australian Health Journal spoke leaders in health care delivery, developing or using technology to further transform healthcare.
00:50
Amanda Cattermole PSM, CEO Australian Digital Health Agency
3:44
Dr Jason King GP, Director of Clinical Services, Gurriny Yealamucka Health
7:41
Steven Flynn, General Manager, Baxter Healthcare Australia and New Zealand
11:52
Grainne O’Loughlin, CEO Karitane
Sharlene Vlahos, Director Education and Development, Karitane
16:15
Zara Lord, CEO and Founder uPaged
-
Addressing Wound Management
The cost of chronic wounds in Australia is estimated to be $3 Billion per year, impacting 420,000 Australians. Not only is this a national economic concern, but more importantly, is the suffering the person may be going through.
Australian Health Journal met with Hayley Ryan, Board Director and Chair at Wounds Australia and Director at WoundRescue to hear her work in chronic wound management, palliative wounds and pressure injury prevention to comfort those living with a wound.
-
Thyroid health into pregnancy
‘Without an adequate amount of thyroid hormone mothers can be exposed to hypertensive disorders of pregnancy, including gestational hypertension and preeclampsia or eclampsia, which affect around 10% of pregnant women and are the leading causes of maternal and neonatal mortality worldwide. Mothers who suffer from hypertensive disorders during pregnancy are at increased risk of long-term cardiovascular consequences and hypertensive disorders in subsequent pregnancies. Evidence also indicates a risk of reduced cognitive ability to their offspring.
‘Knowing if you are genetically predisposed to Hashimoto’s or Graves’ Diseases, which are both thyroid autoimmune disorders is important to be aware of, to ensure all appropriate tests are ordered. Autoimmune disorders may predispose mothers to a thyroid problem during pregnancy’, says Professor Creswell Eastman, who also serves as the ATF’s Principal Medical Advisor.
-
AHJ S1E4: Augmented Reality Learning – Inside MS
Augmented learning now has application seeing the changes in a patient’s brain with Multiple Sclerosis through MRI data. Australian Health Journal met the people behind the augmented reality visor technology that will soon be used to teach trainee doctors the transitional phases of MS.
The technology has been developed by Novartis and in collaboration with the Sydney Neuroimaging Analysis Centre, located within the University of Sydney’s Brain and Mind Centre and Hatch Australia, a creative design team based in Sydney. To date the technology has been well received by neurology health care specialists attending conferences in Melbourne and in Berlin, Germany. We caught with a demo for all other healthcare professionals at the recent ARCS Conference.
